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Letters to the
Editor
Evaluation of surgical trauma and
cardiopulmonary bypass as factors
in inflammatory status after cardiac
surgery
To the Editor:
I read with interest Prondzinsky and col-
leagues’ article1 “Surgical Trauma Affects
the Proinflammatory Status After Cardiac
Surgery to a Higher Degree Than Cardiopul-
monary Bypass.” Because there was no con-
trol group, cardiopulmonary bypass was con-
sidered as the sole factor in development of
generalized inflammatory response after
open procedures. In the past decade, coronary
revascularization without cardiopulmonary
bypass has become an alternative to the con-
ventional on-pump technique. Patients oper-
ated on with this technique thus could repre-
sent a control group. Several studies have
shown no difference between on-pump and
beating-heart surgery with respect to oxygen
metabolism after surgery, pulmonary dys-
function, and other aspects.2,3,4 Different fac-
tors may play a role in development of post-
operative inflammatory response, including
surgical trauma itself, heparin use, anesthetic
challenges, use of suction devices, and peri-
operative stress. Prondzinsky and colleagues1
in their study supported the opinion that the
cardiopulmonary bypass is not the sole factor
in generation of postoperative inflammatory
response. More large, randomized trials
studying different inflammatory pathways
are still required to confirm this finding.
Elsayed M. Elmistekawy, MD
Cardiac Services Department
North West Armed Forces Hospital
Tabuk, Saudi Arabia
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Reply to the Editor:
Thank you for the invitation to respond to
Elsayed M. Elmistekawy=s letter to the ed-
itor. The aim of our study was to show the
effect of trauma and cardiac bypass on the
systemic inflammatory response during
coronary revascularization with and with-
out cardiopulmonary bypass (CPB) to de-
termine the contribution of CPB to the total
amount of interleukin (IL) 6 release during
the perioperative period.
Elmistekawy states that coronary revas-
cularization without CPB should have been
investigated as a control group. In our
study we used patients without surgical
trauma as a positive control group, compar-
ing them with patients with surgical
trauma. The additional IL-6 release during
the perioperative period was used to define
the contribution of CPB by “subtraction” of
the trauma-induced inflammatory response.
We agree an additional “negative control
group” without CPB would have been
helpful to determine the extent of the con-
tribution. Nevertheless, despite the lack of
a negative control group, the published
data, in our opinion, clearly demonstrate
that both aspects, trauma with all related
factors and the CPB, contribute to the peri-
operative inflammatory response. These
conclusions are in agreement with the find-
ings of Hazama and colleagues,1 who dem-
onstrated that off-pump coronary artery re-
vascularization leads to a significant
decreased inflammatory response.
Considering these data by Hazama and
colleagues and other published data, it is
questionable that larger randomized trials
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would be helpful to further elucidate this
point.
We must stress that we did not postulate
that CPB was the sole factor in the inflam-
matory response. Indeed, we documented
that surgical trauma leads to higher IL-6
levels in comparison with the use of CPB
without cardiac surgery.
We are in complete agreement that
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Radial artery for coronary artery
bypass grafting
To the Editor:
I would like to comment on a recent edi-
torial by Mussa and colleagues1 regarding
radial artery grafts for coronary artery by-
pass grafting. In their review of vasospasm
prophylaxis, they state that in addition to
antispasmodic agents during harvesting,
oral calcium-channel antagonists have been
recommended for as long as 1 year after
surgery to prevent delayed vasospasm.
However, my coworkers and I2 recently
reported a study evaluating the effects of
calcium-channel blockers in two random-
ized groups of comparable patients. We
found no differences between patients who
received diltiazem and those who did not,
especially regarding the development of
vascular spasm and angiographic patency 1
year after surgery. Similar results have
been published by other authors.3,4
This evidence is relevant when we con-
sider widespread use of the radial artery for
myocardial revascularization in patients
with different types of coronary disease.
Antispasmodic agents are known to have
adverse consequences, for example, in pa-
tients with acute hemodynamic instability
or with poor left ventricular function.
I agree with Mussa and colleagues1
when they state that there is accumulating
evidence that grafting the radial artery to
coronary targets with moderate stenosis
(70%) results in reduced patency. Angio-
graphic evidence from our study, with a
reproducible and objective method, dem-
onstrated that the degree of native coronary
stenosis was a strong predictor of radial
artery patency (P  .00001; odds ratio
1.08). When the degree of stenosis in the
native coronary artery is 70% or more, the
radial artery graft patency approaches that
of the internal thoracic artery at 1 postop-
erative year.2
I postulate that there is sufficient evi-
dence with which to recommend the use of
radial artery grafts for myocardial revascu-
larization in patients with significant coro-
nary artery stenosis (70%). Topical anti-
spasmodic agents should be used only
during harvesting the conduit. There is no
need for intravenous or oral calcium-channel
blockers, either intraoperatively or during the
first year of follow-up.
The definitive place of the radial artery
compared with other conduits for coronary
grafting will have to await the outcome of
ongoing randomized trials.
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Reply to the Editor:
We thank Dr Moran for his interest in our
editorial concerning the use of radial arter-
ies (RA) as coronary bypass conduits.1 His
letter invites us to expand on two important
points covered in our article:
1. The use of oral calcium channel an-
tagonists as prophylaxis for delayed
vasospasm
2. Use of RA conduits as grafts to cor-
onary vessels with proximal steno-
ses in excess of 70% favours im-
proved long term patency
Concerning the first point, we would
agree that despite previous anecdotal rec-
ommendations there is no substantial evi-
dence for the use of oral calcium channel
antagonists to prevent delayed vasospasm
of RA conduits. Certainly, Gaudino and
associates2 randomized 120 patients re-
ceiving RA grafts to treatment with oral
calcium channel antagonist therapy or not,
and showed no difference in ischemic
symptoms, scintigraphic evidence of isch-
emia, or RA angiographic patency at 5
years. This is consistent with the data pub-
lished by Moran and coworkers.3
Concerning the second point, Moran
and colleagues elegantly demonstrated the
improved patency of RA conduits when
anastomosed to target vessels with high-
grade (70%) proximal stenoses. This
finding was subsequently confirmed in a
larger series with a longer interval to an-
giographic follow-up.4
Graft patency is influenced not only by
the biology and quality of the conduit but
also by physical factors such as luminal
blood pressure and runoff, which govern
luminal blood flow. The concept of com-
petitive flow suggests that graft flow is
influenced by native coronary flow. Royse
and colleagues5 have reported that blood
flow through composite arterial grafts (left
internal thoracic artery–RA T-grafts) fell
by 44% on reintroduction of native coro-
nary flow. Shear stress resulting from flow
activates endothelial nitric oxide synthase
and results in the production of nitric ox-
ide.6 Intuitively, grafted conduits should
fare better in conditions of poor native cor-
onary flow typified by high grade coronary
stenoses, as increased conduit blood flow
will contribute to improved nitric oxide
production.
Shafi Mussa, MA, MRCS
Bikram P. Choudhary, MRCS
David P. Taggart, MD(Hons), PhD, FRCS
Department of Cardiothoracic Surgery
John Radcliffe Hospital
Oxford, United Kingdom
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